Principal Investigator
Namrata Chandhok
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240659
Clinical Trial Summary
TAGALONG Trial: Phase II Study of TAGraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to HypOmethylatiNG Agents
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Leukemia
Contact Information
Phone Number
305-243-2647